Topical Recombinant Human Thrombin Market, Global Outlook and Forecast 2022-2028

June 2022 | 71 pages | ID: T8A697FD6875EN
Market Monitor Global

Abstracts

Topical recombinant human thrombin is a topical thrombin used when capillaries and venules oozing blood and minor bleeding are available and the bleeding is controlled by standard surgical techniques such as sutures, ligation, or cautery. When ineffective or impractical in the population, it can assist in hemostasis.

This report contains market size and forecasts of Topical Recombinant Human Thrombin in global, including the following market information:

Global Topical Recombinant Human Thrombin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Topical Recombinant Human Thrombin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Topical Recombinant Human Thrombin companies in 2021 (%)

The global Topical Recombinant Human Thrombin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2000/Bottle Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Topical Recombinant Human Thrombin include Baxter, Suzhou Zelgen Biopharmaceuticals and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topical Recombinant Human Thrombin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Topical Recombinant Human Thrombin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Topical Recombinant Human Thrombin Market Segment Percentages, by Type, 2021 (%)

• 2000/Bottle
• 5000/Bottle
• Others

Global Topical Recombinant Human Thrombin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Topical Recombinant Human Thrombin Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Topical Recombinant Human Thrombin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Topical Recombinant Human Thrombin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Topical Recombinant Human Thrombin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Topical Recombinant Human Thrombin revenues share in global market, 2021 (%)

Key companies Topical Recombinant Human Thrombin sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Topical Recombinant Human Thrombin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter
• Suzhou Zelgen Biopharmaceuticals
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Topical Recombinant Human Thrombin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Topical Recombinant Human Thrombin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TOPICAL RECOMBINANT HUMAN THROMBIN OVERALL MARKET SIZE

2.1 Global Topical Recombinant Human Thrombin Market Size: 2021 VS 2028
2.2 Global Topical Recombinant Human Thrombin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Topical Recombinant Human Thrombin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Topical Recombinant Human Thrombin Players in Global Market
3.2 Top Global Topical Recombinant Human Thrombin Companies Ranked by Revenue
3.3 Global Topical Recombinant Human Thrombin Revenue by Companies
3.4 Global Topical Recombinant Human Thrombin Sales by Companies
3.5 Global Topical Recombinant Human Thrombin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Topical Recombinant Human Thrombin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Topical Recombinant Human Thrombin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Topical Recombinant Human Thrombin Players in Global Market
  3.8.1 List of Global Tier 1 Topical Recombinant Human Thrombin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Topical Recombinant Human Thrombin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Topical Recombinant Human Thrombin Market Size Markets, 2021 & 2028
  4.1.2 2000/Bottle
  4.1.3 5000/Bottle
  4.1.4 Others
4.2 By Type - Global Topical Recombinant Human Thrombin Revenue & Forecasts
  4.2.1 By Type - Global Topical Recombinant Human Thrombin Revenue, 2017-2022
  4.2.2 By Type - Global Topical Recombinant Human Thrombin Revenue, 2023-2028
  4.2.3 By Type - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
4.3 By Type - Global Topical Recombinant Human Thrombin Sales & Forecasts
  4.3.1 By Type - Global Topical Recombinant Human Thrombin Sales, 2017-2022
  4.3.2 By Type - Global Topical Recombinant Human Thrombin Sales, 2023-2028
  4.3.3 By Type - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
4.4 By Type - Global Topical Recombinant Human Thrombin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Topical Recombinant Human Thrombin Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Topical Recombinant Human Thrombin Revenue & Forecasts
  5.2.1 By Application - Global Topical Recombinant Human Thrombin Revenue, 2017-2022
  5.2.2 By Application - Global Topical Recombinant Human Thrombin Revenue, 2023-2028
  5.2.3 By Application - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
5.3 By Application - Global Topical Recombinant Human Thrombin Sales & Forecasts
  5.3.1 By Application - Global Topical Recombinant Human Thrombin Sales, 2017-2022
  5.3.2 By Application - Global Topical Recombinant Human Thrombin Sales, 2023-2028
  5.3.3 By Application - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
5.4 By Application - Global Topical Recombinant Human Thrombin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Topical Recombinant Human Thrombin Market Size, 2021 & 2028
6.2 By Region - Global Topical Recombinant Human Thrombin Revenue & Forecasts
  6.2.1 By Region - Global Topical Recombinant Human Thrombin Revenue, 2017-2022
  6.2.2 By Region - Global Topical Recombinant Human Thrombin Revenue, 2023-2028
  6.2.3 By Region - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
6.3 By Region - Global Topical Recombinant Human Thrombin Sales & Forecasts
  6.3.1 By Region - Global Topical Recombinant Human Thrombin Sales, 2017-2022
  6.3.2 By Region - Global Topical Recombinant Human Thrombin Sales, 2023-2028
  6.3.3 By Region - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Topical Recombinant Human Thrombin Revenue, 2017-2028
  6.4.2 By Country - North America Topical Recombinant Human Thrombin Sales, 2017-2028
  6.4.3 US Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.4.4 Canada Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.4.5 Mexico Topical Recombinant Human Thrombin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Topical Recombinant Human Thrombin Revenue, 2017-2028
  6.5.2 By Country - Europe Topical Recombinant Human Thrombin Sales, 2017-2028
  6.5.3 Germany Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.4 France Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.5 U.K. Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.6 Italy Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.7 Russia Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.8 Nordic Countries Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.5.9 Benelux Topical Recombinant Human Thrombin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Topical Recombinant Human Thrombin Revenue, 2017-2028
  6.6.2 By Region - Asia Topical Recombinant Human Thrombin Sales, 2017-2028
  6.6.3 China Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.6.4 Japan Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.6.5 South Korea Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.6.6 Southeast Asia Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.6.7 India Topical Recombinant Human Thrombin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Topical Recombinant Human Thrombin Revenue, 2017-2028
  6.7.2 By Country - South America Topical Recombinant Human Thrombin Sales, 2017-2028
  6.7.3 Brazil Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.7.4 Argentina Topical Recombinant Human Thrombin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Topical Recombinant Human Thrombin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Topical Recombinant Human Thrombin Sales, 2017-2028
  6.8.3 Turkey Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.8.4 Israel Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.8.5 Saudi Arabia Topical Recombinant Human Thrombin Market Size, 2017-2028
  6.8.6 UAE Topical Recombinant Human Thrombin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Baxter
  7.1.1 Baxter Corporate Summary
  7.1.2 Baxter Business Overview
  7.1.3 Baxter Topical Recombinant Human Thrombin Major Product Offerings
  7.1.4 Baxter Topical Recombinant Human Thrombin Sales and Revenue in Global (2017-2022)
  7.1.5 Baxter Key News
7.2 Suzhou Zelgen Biopharmaceuticals
  7.2.1 Suzhou Zelgen Biopharmaceuticals Corporate Summary
  7.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
  7.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Major Product Offerings
  7.2.4 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales and Revenue in Global (2017-2022)
  7.2.5 Suzhou Zelgen Biopharmaceuticals Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Topical Recombinant Human Thrombin Major Product Offerings
  7.3.4 Pfizer Topical Recombinant Human Thrombin Sales and Revenue in Global (2017-2022)
  7.3.5 Pfizer Key News

8 GLOBAL TOPICAL RECOMBINANT HUMAN THROMBIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Topical Recombinant Human Thrombin Production Capacity, 2017-2028
8.2 Topical Recombinant Human Thrombin Production Capacity of Key Manufacturers in Global Market
8.3 Global Topical Recombinant Human Thrombin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 TOPICAL RECOMBINANT HUMAN THROMBIN SUPPLY CHAIN ANALYSIS

10.1 Topical Recombinant Human Thrombin Industry Value Chain
10.2 Topical Recombinant Human Thrombin Upstream Market
10.3 Topical Recombinant Human Thrombin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Topical Recombinant Human Thrombin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Topical Recombinant Human Thrombin in Global Market
Table 2. Top Topical Recombinant Human Thrombin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Topical Recombinant Human Thrombin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Topical Recombinant Human Thrombin Revenue Share by Companies, 2017-2022
Table 5. Global Topical Recombinant Human Thrombin Sales by Companies, (K Units), 2017-2022
Table 6. Global Topical Recombinant Human Thrombin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Topical Recombinant Human Thrombin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Topical Recombinant Human Thrombin Product Type
Table 9. List of Global Tier 1 Topical Recombinant Human Thrombin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Topical Recombinant Human Thrombin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Topical Recombinant Human Thrombin Sales (K Units), 2017-2022
Table 15. By Type - Global Topical Recombinant Human Thrombin Sales (K Units), 2023-2028
Table 16. By Application – Global Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Topical Recombinant Human Thrombin Sales (K Units), 2017-2022
Table 20. By Application - Global Topical Recombinant Human Thrombin Sales (K Units), 2023-2028
Table 21. By Region – Global Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Topical Recombinant Human Thrombin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Topical Recombinant Human Thrombin Sales (K Units), 2017-2022
Table 25. By Region - Global Topical Recombinant Human Thrombin Sales (K Units), 2023-2028
Table 26. By Country - North America Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Topical Recombinant Human Thrombin Sales, (K Units), 2017-2022
Table 29. By Country - North America Topical Recombinant Human Thrombin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Topical Recombinant Human Thrombin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Topical Recombinant Human Thrombin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Topical Recombinant Human Thrombin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Topical Recombinant Human Thrombin Sales, (K Units), 2023-2028
Table 38. By Country - South America Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Topical Recombinant Human Thrombin Sales, (K Units), 2017-2022
Table 41. By Country - South America Topical Recombinant Human Thrombin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Topical Recombinant Human Thrombin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Topical Recombinant Human Thrombin Sales, (K Units), 2023-2028
Table 46. Baxter Corporate Summary
Table 47. Baxter Topical Recombinant Human Thrombin Product Offerings
Table 48. Baxter Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Suzhou Zelgen Biopharmaceuticals Corporate Summary
Table 50. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Offerings
Table 51. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Topical Recombinant Human Thrombin Product Offerings
Table 54. Pfizer Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Topical Recombinant Human Thrombin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 56. Global Topical Recombinant Human Thrombin Capacity Market Share of Key Manufacturers, 2020-2022
Table 57. Global Topical Recombinant Human Thrombin Production by Region, 2017-2022 (K Units)
Table 58. Global Topical Recombinant Human Thrombin Production by Region, 2023-2028 (K Units)
Table 59. Topical Recombinant Human Thrombin Market Opportunities & Trends in Global Market
Table 60. Topical Recombinant Human Thrombin Market Drivers in Global Market
Table 61. Topical Recombinant Human Thrombin Market Restraints in Global Market
Table 62. Topical Recombinant Human Thrombin Raw Materials
Table 63. Topical Recombinant Human Thrombin Raw Materials Suppliers in Global Market
Table 64. Typical Topical Recombinant Human Thrombin Downstream
Table 65. Topical Recombinant Human Thrombin Downstream Clients in Global Market
Table 66. Topical Recombinant Human Thrombin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Topical Recombinant Human Thrombin Segment by Type
Figure 2. Topical Recombinant Human Thrombin Segment by Application
Figure 3. Global Topical Recombinant Human Thrombin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Topical Recombinant Human Thrombin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Topical Recombinant Human Thrombin Revenue, 2017-2028 (US$, Mn)
Figure 7. Topical Recombinant Human Thrombin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Topical Recombinant Human Thrombin Revenue in 2021
Figure 9. By Type - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 10. By Type - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Topical Recombinant Human Thrombin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 13. By Application - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Topical Recombinant Human Thrombin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 16. By Region - Global Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 19. US Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 24. Germany Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 25. France Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 33. China Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 37. India Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 40. Brazil Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Topical Recombinant Human Thrombin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Topical Recombinant Human Thrombin Sales Market Share, 2017-2028
Figure 44. Turkey Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Topical Recombinant Human Thrombin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Topical Recombinant Human Thrombin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Topical Recombinant Human Thrombin by Region, 2021 VS 2028
Figure 50. Topical Recombinant Human Thrombin Industry Value Chain
Figure 51. Marketing Channels